Martín, M <br/><br/>
Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.  [electronic resource] 

 -  Thrombosis and haemostasis  May 2013 
 - 909-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH12-09-0670  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--pharmacology<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Annexin A5--blood<br/>Apoptosis<br/>Blood Coagulation<br/>Blood Platelets--drug effects<br/>Blotting, Western<br/>Case-Control Studies<br/>Caspases--blood<br/>Cell-Derived Microparticles--metabolism<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--blood<br/>Peptide Fragments--pharmacology<br/>Platelet Activation--drug effects<br/>Platelet Count<br/>Thrombelastography<br/>Thrombin--metabolism<br/>Thrombocytopenia--blood<br/>Thrombopoietin--blood<br/>Young Adult<br/>bcl-2 Homologous Antagonist-Killer Protein--blood<br/>bcl-2-Associated X Protein--blood